Table 2 CBMs selection and their mapping work
From: Leveraging hybrid biomarkers in clinical endpoint prediction
Covariates | Type | Range | Conversion |
|---|---|---|---|
Gender | Nominal | {Male, Female} | (0,1) |
Age | Real | (42–87) | NA* |
Weights (lbs) | Real | (80–318) | NA |
Smoking years | Real | (0–41) | NA |
Histology | Nominal | {Squamous, Non-Squamous} | (0,1) |
T | Categorical | [1–4] | Number of patients in a stage divided by total number of patients (e.g., 16 patients categorized as T1; those patients were given 0.235 (16/68) value). |
N | Categorical | [0,1,2,3] | |
M | Categorical | [0,1] | |
Tumor size (mm) | Real | (11.7–73.9) | NA |